Showing results (1611-1620 of 1,751) with videos related to

Sort By:
Pageof 176
The Lancet. Oncology|September 2, 2022
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialThomas Powles, Piotr Tomczak, Se Hoon Park, et al.
Haematologica|October 4, 2015
European Myeloma Network guidelines for the management of multiple myeloma-related complicationsEvangelos Terpos, Martina Kleber, Monika Engelhardt, et al.
Frontiers in Oncology|May 14, 2025
Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancerSara Corvigno, Jun Yao, Amma Asare, et al.
The Lancet. Oncology|November 25, 2015
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trialFrancesca Gay, Stefania Oliva, Maria Teresa Petrucci, et al.
International Journal of Bipolar Disorders|December 22, 2022
Lithium induced hypercalcemia: an expert opinion and management algorithmZoltan Kovacs, Peter Vestergaard, Rasmus W Licht, et al.
Nucleic Acids Research|November 16, 2022
The IMG/M data management and analysis system v.7: content updates and new featuresI-Min A Chen, Ken Chu, Krishnaveni Palaniappan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's MacroglobulinemiaChristian Buske, Meletios A Dimopoulos, Alexander Grunenberg, et al.
Blood|January 6, 2016
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myelomaValeria Magarotto, Sara Bringhen, Massimo Offidani, et al.
Ecology|March 19, 2025
Tree diversity shapes the spectral signature of light transmittance in developing forestsLaura J Williams, Kyle R Kovach, J Antonio Guzmán Q, et al.
Haematologica|July 15, 2021
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. HydePellegrino Musto, Monika Engelhardt, Jo Caers, et al.
Pageof 176